Limpet-M Tablet 1 mg+500 mg is a combination oral antidiabetic medication containing Glimepiride (1 mg) and Metformin Hydrochloride (500 mg). It is specifically formulated for the management of type 2 diabetes mellitus in adults whose blood sugar is not adequately controlled with diet, exercise, or monotherapy with either Glimepiride or Metformin.
This dual-action formulation combines the insulin-stimulating effect of Glimepiride with the insulin-sensitizing action of Metformin, providing effective control of fasting and postprandial blood glucose levels. Limpet-M Tablet 1 mg+500 mg is particularly suitable for patients who require a lower dose of Glimepiride while still benefiting from the synergistic glucose-lowering effects of combination therapy.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
The combination of Glimepiride and Metformin works through complementary mechanisms:
Glimepiride (1 mg): Stimulates pancreatic beta cells to secrete insulin in response to elevated blood glucose, enhancing glucose uptake by tissues.
Metformin (500 mg): Improves insulin sensitivity in muscle and adipose tissue, reduces hepatic glucose production, and promotes peripheral glucose utilization.
Synergistic effect: Together, these actions help maintain stable blood glucose levels, minimize postprandial spikes, and reduce hyperglycemia-related complications.
This dual mechanism provides balanced glycemic control while lowering the risk of sudden fluctuations in blood sugar.
Limpet-M Tablet 1 mg+500 mg is indicated for:
Type 2 diabetes mellitus: As combination therapy for patients inadequately controlled on diet, exercise, or monotherapy.
Glycemic optimization: Effective for controlling both fasting and postprandial blood glucose.
Reduction of long-term complications: Consistent use helps prevent diabetes-related issues such as cardiovascular problems, neuropathy, and kidney damage.
This medication is not suitable for patients with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairment.
The usual dose is 1 tablet once or twice daily, taken with meals to minimize gastrointestinal side effects caused by Metformin.
Swallow the tablet whole with water; do not crush or chew.
Dosage may be adjusted based on blood glucose levels, HbA1c, and patient response, under medical supervision.
Regular monitoring of fasting and postprandial glucose, as well as HbA1c, is recommended to assess treatment effectiveness.
Continue following diet, exercise, and lifestyle modifications for optimal glycemic control.
Caution in patients with renal or hepatic impairment; Metformin may rarely cause lactic acidosis.
Hypoglycemia may occur due to Glimepiride, especially in elderly patients, irregular meal patterns, or when combined with other antidiabetic medications.
Inform your physician if you have heart disease, adrenal or pituitary disorders, or a history of lactic acidosis.
Alcohol consumption may increase the risk of hypoglycemia or lactic acidosis.
Consult your doctor before use in pregnancy or breastfeeding.
Common side effects include:
Hypoglycemia (dizziness, sweating, fatigue, confusion)
Gastrointestinal disturbances such as nausea, vomiting, diarrhea, or mild abdominal discomfort
Headache
Mild weight gain due to increased insulin activity
Rare but serious side effects may include:
Severe hypoglycemia requiring urgent medical attention
Lactic acidosis (Metformin-related, very rare)
Allergic reactions (rash, itching, swelling, difficulty breathing)
Hematological abnormalities (rare)
Seek medical attention if severe or persistent symptoms occur.
Store below 30°C in a dry place, away from direct sunlight and moisture. Keep out of reach of children.
Limpet-M Tablet 1 mg+500 mg offers effective dual-action therapy for type 2 diabetes, combining the benefits of Glimepiride and Metformin to stabilize blood sugar, enhance insulin function, and support long-term metabolic health under medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet